Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-drug Analgesia for Perianal Block in Anorectal Surgery
NCT03105674Phase 4Withdrawn
- Sponsor
- Columbia University
- Start
- May 2017
- Primary completion
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
01
Overview
Phase 4, randomised, open-label trial of ropivacaine, ketorolac, triamcinolone acetonide, lidocaine and epinephrine in Hemorrhoids, anal fissure and anal fistula, sponsored by Columbia University. Planned start May 2017; status: withdrawn.
02
Drugs
ropivacaineketorolactriamcinolone acetonidelidocaineepinephrine
03
Conditions
Hemorrhoidsanal fissureanal fistula
Beyond the preview
Go deeper on NCT03105674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03105674.